Pharma Reviews
Pages
Home
Pharma News
US FDA News
Pharma Jobs
Thursday, September 13, 2018
US FDA News: FDA approves new kind of treatment for hairy cell leukemia
FDA approves Lumoxiti (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia
Read more:
FDA approves new kind of treatment for hairy cell leukemia
Newer Post
Older Post
Home
View mobile version